The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering compounded ...

Hims' GLP-1 drugs start at $199 a month, while Wegovy and Ozempic cost over $900 a month — though the price many patients pay depends on their insurance. Earlier this month, Hims ran a Super ...

Alternatively, you can subscribe for a 1-month supply at $30 per month, or choose between a 3- or 6-month subscription which lowers the cost to $20 or $19 per bottle, respectively. Hims recommends ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Hims & Hers Health. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...

Additionally, the FDA last week hindered the ability of compounded drugmakers, including HIMS, to sell lower-cost versions of semaglutide, the weight-loss drug that has proliferated widely.

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a strong buy.